J&J Cypher Panel Date Presages Year-End Approval; Achieve Cleared In EU
This article was originally published in The Gray Sheet
Executive Summary
Clinical data to be reviewed by FDA's Circulatory System Devices Panel Oct. 22 will include nine-month SIRIUS trial safety results on Johnson & Johnson's sirolimus-eluting Cypher stent